News

Researchers at University of Tsukuba have identified multiple T-cell subtypes with unique characteristics in follicular lymphoma, a prevalent type of blood cancer. These T cells regulate the ...
Researchers at University of Tsukuba have identified multiple T-cell subtypes with unique characteristics in follicular lymphoma, a prevalent type of blood cancer. These T cells regulate the ...
New research reveals that tiny amounts of PFAS—widely known as "forever chemicals"—cross the placenta and breast milk to ...
Tsukuba, Japan—T-follicular helper (TFH) ... In this study, 94 cases of TFH lymphoma and 35 cases of peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), ...
Glofitamab is a bispecific CD20-directed CD3 T-cell engager approved under the brand name Columvi ® for the treatment of adults with R/R DLBCL, not otherwise specified or large B-cell lymphoma arising ...
AON community oncology practices across the nation offering groundbreaking immunotherapy to expand treatment options for hard ...
Key Takeaways. Cancer experiences are highly individualized, even among patients with the same type of cancer, challenging common stereotypes. Follicular lymphoma, a blood cancer, often lacks a single ...